RecruitingNCT04811794

Young Survivors at Kantonsspital Aarau, Switzerland

Young Survivors at Kantonsspital Aarau, Switzerland - A Standardized Assessment of Long-Term and Late-Onset Health Events in Survivors of Childhood and Adolescent Cancer


Sponsor

Kantonsspital Aarau

Enrollment

300 participants

Start Date

Mar 15, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The Young Survivors at Kantonsspital Aarau project assesses the prevalence and severity of late effects in survivors of childhood and adolescent cancer according to the modified CTCAE criteria prospectively. The clinical data are generated during regular follow-up care visits, the collection starts directly after completion of treatment and is longitudinally.


Eligibility

Inclusion Criteria10

  • Group A:
  • Children and adolescents who:
  • have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau,
  • have been diagnosed at age 0-18 years,
  • are still in regular follow-up care at the Kantonsspital Aarau,
  • have finished cancer treatment and entered follow-up care, and
  • signed informed consent
  • Group B:
  • Adolescents and adults who:
  • are not in regular follow-up care anymore

Exclusion Criteria3

  • Childhood Cancer Survivors who:
  • are in a palliative situation or
  • have not given consent for further use of medical data

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPhysical examination, diagnostic tests, laboratory tests

Physical examination, diagnostic tests (e.g. lung function test, echocardiography, audiometry), and laboratory tests (e.g. kidney parameter, hormonal levels) depend on examined organ system.

OTHERPersonal history

Personal history on diagnosis, treatment, and socioeconomic factors


Locations(1)

Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau

Aarau, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04811794


Related Trials